CCL2 Accelerates Microglia-Mediated Aβ Oligomer Formation and Progression of Neurocognitive Dysfunction

• Tomomi Kiyota,

  Affiliations Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯
• Masaru Yamamoto,

  Affiliations Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯
• Huangui Xiong,

  Affiliations Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯
• Mary P. Lambert,

  Affiliation Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois, United States of America

  ⨯
• William L. Klein,

  Affiliation Department of Neurobiology and Physiology, Northwestern University, Evanston, Illinois, United States of America

  ⨯
• Howard E. Gendelman,

  Affiliations Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Internal Medicine, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯
• Richard M. Ransohoff,

  Affiliation Department of Neurosciences, Lerner Research Institute, Cleveland Clinic Foundation, Cleveland, Ohio, United States of America

  ⨯
• Tsuneya Ikezu

  * E-mail: tikezu@unmc.edu

  Affiliations Center for Neurovirology and Neurodegenerative Disorders, University of Nebraska Medical Center, Omaha, Nebraska, United States of America, Department of Pharmacology and Experimental Neuroscience, University of Nebraska Medical Center, Omaha, Nebraska, United States of America

  ⨯